Triple-negative breast cancer (TNBC) is the most malignant and aggressive molecular subtype of breast cancer that lacks the expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene PGR and breast carcinoma.